Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis
Clinically distinct GI phenotypes exist among patients with SSc. These phenotypes are not only distinguished by GI and extra-intestinal SSc clinical complications, but they are also temporally distinct. Distinct autoantibody profiles are associated strongly with more severe GI disease.
Authors
- Ami A. Shah (ORCID: https://orcid.org/0000-0002-1139-2009)
- Scott L. Zeger (ORCID: https://orcid.org/0000-0001-8907-1603)
- Christopher A. Mecoli (ORCID: https://orcid.org/0000-0002-1429-8392)
- Allan C. Gelber (ORCID: https://orcid.org/0000-0001-8463-311X)
- Laura K. Hummers (ORCID: https://orcid.org/0000-0002-4864-4011)
- Michael Hughes (ORCID: https://orcid.org/0000-0003-3361-4909)
- Zsuzsanna H. McMahan (ORCID: https://orcid.org/0000-0001-6461-8940)
- Julie J. Paik (ORCID: https://orcid.org/0000-0001-8436-1601)
- Fredrick M. Wigley
- Jamie Perin (ORCID: https://orcid.org/0000-0002-5482-6620)
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- University of Manchester (GB)
- The University of Texas Health Science Center (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2024-08-30
- DOI
- https://doi.org/10.1093/rheumatology/keae469
- Citations
- 14
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 5.95
Funders
- Rheumatology Research Foundation
- Jerome L. Greene Foundation
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases